OptiBiotix Health (LON:OPTI) Stock Price Down 5.4% – Should You Sell?

OptiBiotix Health Plc (LON:OPTI) traded down 5.4% during mid-day trading on Thursday . The company traded as low as GBX 6.75 and last traded at GBX 7. 408,845 shares were traded during trading, a decline of 21% from the average session volume of 520,055 shares. The stock had previously closed at GBX 7.40.

OptiBiotix Health Price Performance

The company has a market capitalization of £6.36 million, a PE ratio of -205.17 and a beta of 1.71. The company’s fifty day moving average is GBX 6.91 and its 200-day moving average is GBX 8.75.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.